Search

Your search keyword '"Hellemans R"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Hellemans R" Remove constraint Author: "Hellemans R" Language english Remove constraint Language: english
61 results on '"Hellemans R"'

Search Results

1. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

5. Avacopan for the Treatment of ANCA-Associated Vasculitis

7. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

10. Single-Center Case Series of Donor-Related Malignancies: Rare Cases With Tremendous Impact.

14. The 3-Step Model of informed consent for living kidney donation : a proposal on behalf of the DESCaRTES Working Group of the European Renal Association

16. Time trends in preemptive kidney transplantation in Europe: an ERA registry study.

17. 2-Step-Scores with optional nephropathology for the prediction of adverse outcomes for brain-dead donor kidneys in Eurotransplant.

18. Immunosuppression of HLA identical living-donor kidney transplant recipients: A systematic review.

19. Pre-transplant HbA1c and risk of diabetes mellitus after kidney transplantation: a single center retrospective analysis.

20. The 3-Step Model of informed consent for living kidney donation: a proposal on behalf of the DESCaRTES Working Group of the European Renal Association.

21. Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism.

22. Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?

24. Kidney transplantation during mass disasters - from COVID-19 to other catastrophes A Consensus Statement by the DESCARTES Working Group and Ethics Committee of the ERA.

25. Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis.

26. Ethical and medical dilemmas in paid living kidney donor transplantation.

27. SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies.

28. Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group.

29. Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders.

30. Is the failure of recent trials on withdrawal of calcineurin inhibitors due to inadequate mycophenolic acid dosing?

31. Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.

32. Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention.

33. Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry.

34. Timing of the pre-transplant workup for renal transplantation: is there room for improvement?

35. Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA.

36. Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer (excluding non-melanoma skin cancer): an overview of the available evidence and guidance for shared decision-making.

38. Recurrence and Outcome of Anti-Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation.

39. Does kidney transplantation with a standard or expanded criteria donor improve patient survival? Results from a Belgian cohort.

40. The role of HLA-DP mismatches and donor specific HLA-DP antibodies in kidney transplantation: a case series.

41. A split strategy to prevent cytomegalovirus after kidney transplantation using prophylaxis in serological high-risk patients and a pre-emptive strategy in intermediate-risk patients: Combining the best of two options?

42. "Does Perioperative Patient Perfusion Obviate the Need for Kidney Machine Perfusion?" A Retrospective Analysis of Patients Receiving a Kidney From "Donation After Circulatory Death" Donors.

43. Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis.

44. A rare case of hemodialysis-related portosystemic encephalopathy and review of the literature.

46. Transplantation in older individuals: is it really better than dialysis?

48. Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys?

49. Prediction of delayed graft function using different scoring algorithms: A single-center experience.

50. Do elderly recipients really benefit from kidney transplantation?

Catalog

Books, media, physical & digital resources